# A Comparative Study to Evaluate the Effects and Mechanism of Action of Dysport®, Botox® and Xeomin® in the Extensor Digitorum Brevis Model in Healthy Adult Male Participants

> **NCT04970407** · PHASE1 · COMPLETED · sponsor: **Ipsen** · enrollment: 45 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **BIOLOGICAL:** Botulinum toxin type A
- **BIOLOGICAL:** Botulinum toxin type A
- **BIOLOGICAL:** Botulinum toxin type A

## Key facts

- **NCT ID:** NCT04970407
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-06
- **Primary completion:** 2022-03-16
- **Final completion:** 2022-06-08
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2025-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04970407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04970407, "A Comparative Study to Evaluate the Effects and Mechanism of Action of Dysport®, Botox® and Xeomin® in the Extensor Digitorum Brevis Model in Healthy Adult Male Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04970407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*